4//SEC Filing
Bogonis Paul C 4
Accession 0001375727-13-000003
CIK 0001277270other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 6:40 PM ET
Size
9.6 KB
Accession
0001375727-13-000003
Insider Transaction Report
Form 4
Telanetix,IncTNIX
Bogonis Paul C
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2013-01-10+51,865→ 51,865 totalExp: 2023-01-10→ Common Stock (51,865 underlying)
Holdings
- 2,000
Common Stock $.0001 par value per share
Footnotes (6)
- [F1](1) 50% of the option shall have an option price of $3.00000 per share ("Tranche 1 Option"); 16.65% of the option shall have an option price of $5.77800 per share ("Tranche 2 Option"); 16.65% of the option shall have an option price of $5.77800 per share ("Tranche 3 Option"); and 16.7% of the option shall have an option price of $5.77800 per share ("Tranche 4 Option").
- [F2](2) (a) Tranche 1 Option shall vest 100% of the options upon affiliates of Hale Capital Partners ("Hale") receiving cash proceeds in return on its invested capital (whether such cash derives from interest payments, debt repayment, dividends, distributions, sale of equity or otherwise) in the Company and its subsidiaries which cash proceeds equal no less than one times its invested capital plus a 4% annual return on such invested capital, compounded annually (the "Tranche 1 Return") and subject to the Reporting Person's continued employment in good standing with the Company on such vesting date. Tranche 1 vesting was achieved on December 14, 2012 as a result of the term loan evidenced by the Loan Agreement and East West Note, Senior Secured Notes of Telanetix in favor of HCP-TELA, LLC ("HCP"), EREF-TELA, LLC ("EREF"), and CBG-TELA, LLC ("CBG").
- [F3](2) (a) Continued. Notwithstanding the foregoing and the failure of Hale to have achieved the Tranche 1 Return, the Tranche 1 Option shall vest with 10% of the Tranche 1 Option on the first anniversary of the Grant Date and 2.5% of the Tranche 1 Option at the end of each of the next eight quarters thereafter through the third anniversary of the Grant Date (for an aggregate of 30% of the Tranche 1 Options), subject to the Reporting Person's continued employment in good standing with the Company on each such vesting date.
- [F4](2) (b) Tranche 2 Option shall vest 100% of the options upon Hale receiving cash proceeds in return on its invested capital (whether such cash derives from interest payments, debt repayment, dividends, distributions, sale of equity or otherwise) in the Company and its subsidiaries which cash proceeds equal no less than two times its invested capital plus a 4% annual return on such invested capital, compounded annually and subject to the Reporting Person's continued employment in good standing with the Company on such vesting date.
- [F5](2) (c) Tranche 3 Option shall vest 100% of the options upon Hale receiving cash proceeds in return on its invested capital (whether such cash derives from interest payments, debt repayment, dividends, distributions, sale of equity or otherwise) in the Company and its subsidiaries which cash proceeds equal no less than three times its invested capital plus a 4% annual return on such invested capital, compounded annually and subject to the Reporting Person's continued employment in good standing with the Company on such vesting date.
- [F6](2) (d) Tranche 4 Option shall vest 100% of the options upon Hale receiving cash proceeds in return on its invested capital (whether such cash derives from interest payments, debt repayment, dividends, distributions, sale of equity or otherwise) in the Company and its subsidiaries which cash proceeds equal no less than four times its invested capital plus a 4% annual return on such invested capital, compounded annually and subject to the Reporting Person's continued employment in good standing with the Company on such vesting date.
Documents
Issuer
Telanetix,Inc
CIK 0001277270
Entity typeother
Related Parties
1- filerCIK 0001375727
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 6:40 PM ET
- Size
- 9.6 KB